Pharmaceutical intermediates are chemical raw materials or products used in the pharmaceutical synthesis process. They effectively promote the R&D process of new and generic drugs, and some key intermediates may also become critical factors restricting process development. In compliance with the regulations and guiding principles of the ICH and NMPA/FDA, our CMC Department can provide clients with integrated pharmaceutical services, including the development of pharmaceutical intermediate production processes and the optimization of commercial production, as well as all registrations and filings.
Download
Service we provideTechnical Platform:
During the synthesis process to the scale up process in the laboratory, errors and risks must be controlled. In the development of innovative drugs, the assessment of the safety of chemical processes and equipment is extremely important.
The solid screening platform of Medicilon process department strictly complies with the regulations and regulatory requirements of the NMPA, FDA and other regulatory authorities.
Medicilon's pharmaceutical solid-state research service platform is dedicated to crystal form research services in the development of new drugs and generic drugs.
Relevant laboratories
marketing@medicilon.com
